Celltrion “Anticancer Drug Vegzelma Published in International Journal”

조선일보

Lean Right

Factuality

Ownership

Celltrion announced on the 14th that research on Vegzelma, a treatment for breast cancer and metastatic colorectal cancer, has been published in an international academic journal. Vegzelma is a biosimilar (a generic version of a biopharmaceutical) of Avastin from the Swiss pharmaceutical company Roche. Celltrion analyzed serum concentrations and other parameters from 843 participants in Vegzelma's Phase 1 and 3 clinical trials. As a result, the …